Srividhya Venkataraman*, Tauqeer Ahmad, Mounir A. Haidar and Kathleen L. Hefferon Pages 31 - 43 ( 13 )
Background: With an increase in comprehension of the molecular biology of viruses, there has been a recent surge in the application of virus sequences and viral gene expression strategies towards the diagnosis and treatment of diseases.
Results: The scope of the patenting landscape has widened as a result and the current review discusses patents pertaining to live / attenuated viral vaccines. The vaccines addressed here have been developed by both conventional means as well as by the state-of-the-art genetic engineering techniques.
Conclusion: This review also addresses the applications of these patents for clinical and biotechnological purposes.
Attenuated virus, vaccines, antiviral agents, inactivated viruses, virulence factors, adjuvants.
Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario M5S 3B2, Cell and Systems Biology, University of Toronto, M5G 3B2A, Toronto, Cell and Systems Biology, University of Toronto, M5G 3B2A, Toronto, Cell and Systems Biology, University of Toronto, M5G 3B2A, Toronto